| |
|
 |
BIOSPECTRA IS PARTICIPATING IN DCAT WEEK, NYC MARCH 18-21ST AND WILL BE LOCATED AT THE LOTTE PALACE, 455 MADISON AVE, SUITE 1203
https://www.biospectra.us/biospectra-is-participating-in-dcat-week-nyc-march-18-21st |
|
 |
BIOSPECTRA WILL BE EXHIBITING AT AAPS PHARMSCI 360
IN WASHINGTON, DC ON NOVEMBER 4-7TH, BOOTH #1911!
https://www.biospectra.us/2018-aaps-pharmsci-360 |
|
 |
BIOSPECTRA ANNOUNCES THE LAUNCH OF THREE
“PARENTERAL GRADE” CARBOHYDRATES
https://www.biospectra.us/biospectra-announces-the-launch-of-three-"parenteral-grade"-carbohydrate |
|
 |
BIOSPECTRA ANNOUNCES THE LAUNCH OF LOW-CHLORIDE,
10N SODIUM HYDROXIDE IN BULK
https://www.biospectra.us/biospectra-announces-the-launch-of-low-chloride,-10n-sodium-hydroxide-in-bulk |
|
 |
BIOSPECTRA ANNOUNCES EXPANDED KILO-SCALE SYNTHESIS AND NEW SYNTHETIC ROUTES FOR BIOLOGICAL BUFFERS
https://www.biospectra.us/biospectra-announces-expanded-kilo-scale-synthesis-and-new-synthetic-routes-for-biological-buffers |
|
 |
BIOSPECTRA WILL BE EXHIBITING AT CPHI WORLDWIDE,
OCTOBER 9 -11TH IN MADRID, SPAIN, BOOTH #5A70!
https://www.biospectra.us/biospectra-will-be-exhibiting-at-cphi-worldwide-october-9-11th-in-madrid-spain-booth-5a70 |
|
 |
BIOSPECTRA WILL BE EXHIBITING AT PHARMA CHEMOUTSOURCING,
SEPTEMBER 17-19TH IN LONG BRANCH, NJ, BOOTH #40!
http://www.biospectra.us/biospectra-will-be-exhibiting-at-pharma-chemoutsourcing-september-17-19th-in-long-branch-nj-booth-40 |
|
 |
DETERMINING THE VALUE OF RE-SHORING DRUG INGREDIENT MANUFACTURING
https://www.biospectra.us/determining-the-value-of-re-shoring-drug-ingredient-manufacturing |
|
 |
BIOSPECTRA TO PRESENT AT CONVENTION FOR PHARMACEUTICAL INGREDIENTS (CPhI) NORTH AMERICA
https://www.biospectra.us/biospectra-to-present-at-convention-for-pharmaceutical-ingredients-cphi-north-america |
|
 |
BIOSPECTRA TO PRESENT AT EXCIPIENTFEST 2017
https://www.biospectra.us/biospctra-to-present-at-excipientfest-2017 |
|
 |
EXECUTIVE INTERVIEW: Rick Mutchler, CEO
https://drug-dev.com/executive-interview-biospectra-trusted-reliabe-source-for-intermediates/ |
|
 |
PRODUCT SUITABILITY: Dora Meissner, Regulatory Manager
http://www.pharmtech.com/product-suitability-intended-end-use |
|
 |
US MANUFACTURED API TROMETHAMINE NOW AVAILABLE FROM FDA-REGISTERED FACILITY
https://drug-dev.com/us-manufactured-api-tromethamine-from-fda-registered-facility-available-quarter4-2014/ |
|
 |
US MANUFACTURED API UREA NOW AVAILABLE FROM FDA-REGISTERED FACILITY
https://drug-dev.com/us-manufactured-api-urea-from-fda-registered-facility-available-q4-2014/ |
|
 |
NEW CONTRACT MANUFACTURING FACILITY
http://www.pharmtech.com/biospectra-opens-contract-manufacturing-facility |
|
 |
HEPES, MOPS & MES/Secure Supply Chain
https://drug-dev.com/cgmp-hepes-mops-mes-available-with-full-traceability-secure-supply-chain/ |
|
 |
INDUSTRY LEADING CUSTOM MANUFACTURING CAPABILITIES
https://drug-dev.com/biospectra-offers-industry-leading-custom-manufacturing-capabilities/ |
|
 |
PHARMA & BIOPHARMA PRODUCT LAUNCH
http://www.contractpharma.com/contents/view_breaking-news/2014-07-24/biospectra-launches-contract-manufacturing-services/ |
